home / stock / arct / arct quote
Last: | $30.50 |
---|---|
Change Percent: | -0.88% |
Open: | $29.27 |
Close: | $30.50 |
High: | $30.99 |
Low: | $28.86 |
Volume: | 347,668 |
Last Trade Date Time: | 05/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$30.5 | $29.27 | $30.5 | $30.99 | $28.86 | 347,668 | 05-16-2024 |
$29.015 | $30.11 | $29.015 | $30.65 | $28.87 | 293,131 | 05-15-2024 |
$29.74 | $29.25 | $29.74 | $30.42 | $28.54 | 836,129 | 05-14-2024 |
$28.72 | $27.8 | $28.72 | $28.89 | $27.76 | 277,394 | 05-13-2024 |
$27.26 | $26.9 | $27.26 | $27.79 | $26.32 | 530,924 | 05-10-2024 |
$26.79 | $29.08 | $26.79 | $29.08 | $26.28 | 548,718 | 05-09-2024 |
$27.21 | $27.11 | $27.21 | $27.46 | $26.67 | 317,880 | 05-08-2024 |
$27.56 | $27.34 | $27.56 | $27.85 | $27.05 | 474,271 | 05-07-2024 |
$27.32 | $27.06 | $27.32 | $27.9 | $26.715 | 274,832 | 05-06-2024 |
$27.27 | $27.64 | $27.27 | $28.35 | $26.765 | 671,649 | 05-03-2024 |
$26.52 | $28 | $26.52 | $28.14 | $25.995 | 692,610 | 05-02-2024 |
$27.91 | $25.56 | $27.91 | $28.425 | $25.55 | 939,753 | 05-01-2024 |
$25.57 | $26.43 | $25.57 | $26.43 | $25.44 | 600,156 | 04-30-2024 |
$26.63 | $26.85 | $26.63 | $27.515 | $26.43 | 296,545 | 04-29-2024 |
$26.55 | $26.28 | $26.55 | $26.86 | $25.84 | 275,687 | 04-26-2024 |
$26.17 | $26.09 | $26.17 | $26.8 | $25.41 | 526,939 | 04-25-2024 |
$26.98 | $28.2 | $26.98 | $28.38 | $26.585 | 265,736 | 04-24-2024 |
$27.93 | $27.03 | $27.93 | $28.8 | $27.03 | 314,124 | 04-23-2024 |
$27.06 | $26.17 | $27.06 | $27.735 | $25.96 | 327,983 | 04-22-2024 |
$25.98 | $26.06 | $25.98 | $26.88 | $25.57 | 626,328 | 04-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
Arcturus Therapeutics Ltd. Company Name:
ARCT Stock Symbol:
NASDAQ Market:
Tesla CEO Elon Musk does not seem to agree with Republicans at least on one thing. On Wednesday, the billionaire, true to his credentials as a tech...
Commercial manufacture of Kostaive ® on track for delivery of initial 4 million doses in Q3 Kostaive ® European Marketing Authorization Application approval decision expected Q3 Multiple Kostaive ® Phase 3 trials further demonstrate breadth and durabilit...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...